For Week 2, you will examine how patient factors may influence pharmacokinetic and pharmacodynamic processes of pharmacotherapeutics used in the treatment of cardiovascular disorders. You also explore ways to improve drug therapy plans for cardiovascular disorders based on patient factors and overall health needs.
When writing your Week 2 Assignment, consider the following scenario:
AB is an 86-year-old female admitted to the emergency department with delirium. Her spouse is with her and verifies that LM adheres to the medications she is currently prescribed. She does not self-monitor her BP or heart rate at home.
PMH:
A fib x 1 month
HTN x 10 years
CKD x 5 years
Osteoarthritis x 7 years
GERD x 20 years
Allergies:
NKDA
Medications:
Digoxin 0.25mg once daily
Metoprolol succinate 25mg once daily
Warfarin 3 mg once daily
APAP 650mg three times daily
Omeprazole 20mg once daily
MVI once daily
Social History:
Married to husband for 57 years
No smoking, alcohol, limited daily exercise (short walks each morning)
Family History:
None reported
Vitals:
Ht: 5’4”
Wt: 113 lbs
HR: 52 bpm
BP: 101/58
Labs:
Gluc 109
Na 138
K 4.0
Cl 99
CO2 27
BUN 33
Scr 1.2
INR 3.8
Dig 2.4
Physical Exam:
Elderly female with altered level of consciousness
No signs of bruising, bleeding, or other injury
Evidence-based clinical practice guidelines are fundamental to clinical practice, as they assist providers with clinical decision making. I have attached some applicable guidelines below for your reference.
Have a great week!
2017 ACC-AHA Guideline Mgmt HTN in Adults.pdf
2018 AHA-ACC Guideline on Mgmt Blood Cholesterol.pdf
2022 AHA-ACC-HFSA Guideline for the Mgmt of HF.pdf
ASH 2018 Guidelines Mgmt of VTE_Optimal Anticoag.pdf
2019 AHA-ACC-HRS Guideline for Mgmt A Fib.pdf
2017 AHA-ACC Guideline Mgmt Valvular Heart Disease.pdf
